Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study
Titel:
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study
Auteur:
Guida, Annalisa Gili, Alessio Mosillo, Claudia Maruzzo, Marco Lai, Eleonora Pierantoni, Francesco Bimbatti, Davide Basso, Umberto Fornarini, Giuseppe Rebuzzi, Sara Elena CalabrĂ², Fabio Cerbone, Linda Caserta, Claudia Sirgiovanni, Grazia Serafin, Debora Caffo, Orazio Scagliarini, Sarah Bracarda, Sergio